The startup develops medical software applications that utilize a scientific platform to validate algorithms for screening and monitoring eye diseases. This technology provides eye doctors and patients with real-time analytics of eye health data, enabling timely interventions and improved patient outcomes.
Funding
$710K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Patients with retinal conditions, such as age-related macular degeneration and diabetic macular edema, often experience a significant burden in their daily lives, requiring frequent monitoring to prevent vision loss. Traditional methods of monitoring rely on clinic visits, which can be inconvenient and costly, leading to potential delays in detecting and addressing worsening conditions.
Solution
Alleye offers a mobile application that enables patients to self-monitor their vision for signs of retinal disease progression. The app uses a hyperacuity test, where patients align a central dot with two flanking dots to detect distortions in their vision. By regularly using the app, patients can track their medical outcomes, record treatments such as injections, and provide feedback to their eye care professionals through questionnaires. The app also includes a calendar to remind patients of upcoming appointments, tests, and surveys, facilitating better adherence to their treatment plans and strengthening the connection between patients and their healthcare providers.
Target Audience
The primary target audience includes individuals at risk of developing retinal diseases, those undergoing treatment for conditions like age-related macular degeneration or diabetic macular edema, and healthcare professionals seeking to monitor their patients' eye health remotely.
Features
- Mobile application for both iOS and Android platforms, compatible with smartphones and tablets
- Hyperacuity test based on Vernier alignment to detect metamorphopsia
- Integration of Patient Reported Outcome Measures (PROMs) for subjective health status tracking
- Injection logging to monitor the impact of treatments on eye health
- Tracking of medical outcomes such as central retinal thickness and visual acuity
- Personal calendar for reminders of appointments, tests, and surveys
- Secure data transmission and storage with TLS 1.3 encryption and AES-256 encryption on the mobile device
- Compliant with EU GDPR, HIPAA, and FDA Cybersecurity in Medical Devices requirements